BioNTech’s COVID-19 vaccine revenue forecasts lower than expected
BioNTech expects revenue from its COVID-19 vaccines to hit €5bn (US$5.3bn) in 2023, which would be lower than market expectations.
Archives for March 27, 2023
EpiBiologics emerges with $50m and protein degradation platform
The biotech is launched with an antibody-based protein degradation platform, with technology licensed from UCSF.
Takeda initiates largest ever investment in Japanese manufacturing capacity
The company will build a new manufacturing facility for plasma-derived therapies, based in Osaka, Japan.
Remedium and Exothera partner on scale-up of gene therapy for osteoarthritis
Remedium Bio, a US biotech, and Exothera, a Belgian CDMO, have established a collaborative agreement in relation to the US firm’s disease modifying gene therapy for osteoarthritis, AAV2-FGF18.
UPS Healthcare opens logistics facility in Germany
UPS Healthcare says its first dedicated healthcare logistics facility in Giessen, Germany is now up and running. Up to 150 jobs have been created as a result of this operation, added the provider.